Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Achilles Tendon | 6 | 2019 | 12 | 2.200 |
Why?
|
| Tendons | 11 | 2019 | 174 | 1.780 |
Why?
|
| Tendinopathy | 4 | 2019 | 38 | 1.470 |
Why?
|
| Biomechanical Phenomena | 22 | 2019 | 536 | 1.110 |
Why?
|
| Wound Healing | 4 | 2015 | 107 | 1.000 |
Why?
|
| Cartilage, Articular | 5 | 2015 | 268 | 0.950 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2019 | 16 | 0.910 |
Why?
|
| ADAM Proteins | 3 | 2013 | 41 | 0.820 |
Why?
|
| Rotator Cuff | 6 | 2019 | 213 | 0.760 |
Why?
|
| Animals | 18 | 2019 | 3270 | 0.750 |
Why?
|
| Shoulder | 5 | 2015 | 144 | 0.630 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2019 | 2 | 0.620 |
Why?
|
| Bursitis | 1 | 2019 | 9 | 0.610 |
Why?
|
| Bursa, Synovial | 2 | 2018 | 7 | 0.580 |
Why?
|
| Hyaluronan Synthases | 1 | 2018 | 4 | 0.570 |
Why?
|
| Calcaneus | 1 | 2018 | 3 | 0.570 |
Why?
|
| Tendon Injuries | 4 | 2015 | 154 | 0.570 |
Why?
|
| Lactic Acid | 1 | 2018 | 6 | 0.570 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 8 | 0.570 |
Why?
|
| Glucose | 1 | 2018 | 45 | 0.560 |
Why?
|
| Aggrecans | 3 | 2013 | 52 | 0.530 |
Why?
|
| Bone Screws | 4 | 2013 | 127 | 0.520 |
Why?
|
| Bone-Patellar Tendon-Bone Grafting | 3 | 2013 | 26 | 0.490 |
Why?
|
| Signal Transduction | 1 | 2018 | 387 | 0.480 |
Why?
|
| Male | 30 | 2019 | 12459 | 0.480 |
Why?
|
| Suture Anchors | 7 | 2014 | 61 | 0.470 |
Why?
|
| Capsaicin | 1 | 2015 | 8 | 0.460 |
Why?
|
| Chondrogenesis | 1 | 2015 | 24 | 0.460 |
Why?
|
| Arthroplasty, Subchondral | 1 | 2015 | 18 | 0.460 |
Why?
|
| Mice, Knockout | 4 | 2018 | 276 | 0.440 |
Why?
|
| Shoulder Joint | 7 | 2019 | 513 | 0.410 |
Why?
|
| Tibia | 6 | 2014 | 197 | 0.400 |
Why?
|
| Osteotomy | 4 | 2019 | 123 | 0.390 |
Why?
|
| Mice | 5 | 2019 | 1238 | 0.380 |
Why?
|
| Exercise Therapy | 1 | 2012 | 84 | 0.360 |
Why?
|
| Knee Injuries | 2 | 2013 | 127 | 0.360 |
Why?
|
| Stress, Mechanical | 6 | 2015 | 129 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 363 | 0.340 |
Why?
|
| Joint Instability | 4 | 2011 | 312 | 0.330 |
Why?
|
| ADAMTS5 Protein | 3 | 2018 | 20 | 0.330 |
Why?
|
| Anterior Cruciate Ligament | 4 | 2013 | 137 | 0.310 |
Why?
|
| Suture Techniques | 6 | 2019 | 112 | 0.310 |
Why?
|
| Weight-Bearing | 7 | 2013 | 134 | 0.310 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 526 | 0.300 |
Why?
|
| Absorbable Implants | 1 | 2009 | 17 | 0.290 |
Why?
|
| Female | 25 | 2019 | 12939 | 0.290 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2009 | 19 | 0.290 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 226 | 0.290 |
Why?
|
| Rabbits | 4 | 2015 | 166 | 0.270 |
Why?
|
| Cadaver | 13 | 2014 | 284 | 0.270 |
Why?
|
| Plastic Embedding | 1 | 2007 | 1 | 0.260 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 3 | 2013 | 139 | 0.250 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2019 | 40 | 0.250 |
Why?
|
| Stifle | 1 | 2006 | 9 | 0.250 |
Why?
|
| Humans | 25 | 2019 | 22912 | 0.240 |
Why?
|
| Genetic Variation | 1 | 2006 | 69 | 0.240 |
Why?
|
| Random Allocation | 3 | 2018 | 102 | 0.240 |
Why?
|
| Models, Animal | 5 | 2015 | 103 | 0.230 |
Why?
|
| Arthroscopy | 7 | 2014 | 552 | 0.230 |
Why?
|
| Collagen Type III | 2 | 2015 | 9 | 0.220 |
Why?
|
| Collagen Type I | 2 | 2015 | 14 | 0.220 |
Why?
|
| Arthroplasty | 3 | 2019 | 107 | 0.210 |
Why?
|
| Middle Aged | 18 | 2019 | 7911 | 0.210 |
Why?
|
| Glenoid Cavity | 2 | 2014 | 31 | 0.200 |
Why?
|
| Proteoglycans | 2 | 2015 | 120 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2015 | 152 | 0.200 |
Why?
|
| Allografts | 2 | 2013 | 147 | 0.190 |
Why?
|
| Muscle, Skeletal | 4 | 2013 | 341 | 0.190 |
Why?
|
| Transplantation, Homologous | 6 | 2013 | 198 | 0.180 |
Why?
|
| Patellar Ligament | 2 | 2013 | 35 | 0.180 |
Why?
|
| Humerus | 2 | 2013 | 89 | 0.180 |
Why?
|
| Acetabulum | 2 | 2013 | 161 | 0.180 |
Why?
|
| Collagen | 2 | 2018 | 81 | 0.160 |
Why?
|
| Tenodesis | 2 | 2013 | 139 | 0.160 |
Why?
|
| Regeneration | 1 | 2019 | 15 | 0.150 |
Why?
|
| Injections | 1 | 2019 | 42 | 0.150 |
Why?
|
| Orthopedic Procedures | 3 | 2010 | 225 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 161 | 0.150 |
Why?
|
| Menisci, Tibial | 2 | 2011 | 95 | 0.150 |
Why?
|
| Small Leucine-Rich Proteoglycans | 1 | 2018 | 1 | 0.140 |
Why?
|
| Dermatan Sulfate | 1 | 2018 | 1 | 0.140 |
Why?
|
| Chondroitin Sulfates | 1 | 2018 | 5 | 0.140 |
Why?
|
| Aerobiosis | 1 | 2018 | 1 | 0.140 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 8 | 0.140 |
Why?
|
| Glycolysis | 1 | 2018 | 12 | 0.140 |
Why?
|
| Pressure | 2 | 2015 | 50 | 0.140 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 34 | 0.140 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 23 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 57 | 0.140 |
Why?
|
| Cell Survival | 2 | 2015 | 99 | 0.130 |
Why?
|
| Gene Expression | 2 | 2016 | 178 | 0.120 |
Why?
|
| Gamma Rays | 2 | 2013 | 12 | 0.120 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 21 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2016 | 129 | 0.110 |
Why?
|
| Bone Transplantation | 2 | 2014 | 155 | 0.110 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 74 | 0.110 |
Why?
|
| Aged | 11 | 2014 | 7442 | 0.110 |
Why?
|
| Ilium | 1 | 2014 | 28 | 0.110 |
Why?
|
| Rotator Cuff Injuries | 3 | 2012 | 226 | 0.100 |
Why?
|
| Materials Testing | 1 | 2014 | 102 | 0.100 |
Why?
|
| Hyaline Cartilage | 1 | 2013 | 8 | 0.100 |
Why?
|
| Integrins | 1 | 2013 | 10 | 0.100 |
Why?
|
| Physical Conditioning, Animal | 1 | 2013 | 6 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2010 | 314 | 0.100 |
Why?
|
| Femur Neck | 1 | 2012 | 14 | 0.100 |
Why?
|
| Femur Head | 1 | 2012 | 40 | 0.090 |
Why?
|
| Rats | 3 | 2010 | 623 | 0.090 |
Why?
|
| Pain, Postoperative | 1 | 2015 | 272 | 0.090 |
Why?
|
| Bupivacaine | 1 | 2012 | 39 | 0.090 |
Why?
|
| Anesthetics, Local | 1 | 2012 | 71 | 0.090 |
Why?
|
| Fibril-Associated Collagens | 1 | 2011 | 1 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 22 | 0.090 |
Why?
|
| Osseointegration | 1 | 2012 | 69 | 0.090 |
Why?
|
| Organ Size | 1 | 2011 | 87 | 0.090 |
Why?
|
| Adult | 8 | 2014 | 6924 | 0.090 |
Why?
|
| Alpha-Globulins | 1 | 2011 | 1 | 0.090 |
Why?
|
| Horse Diseases | 1 | 2011 | 2 | 0.090 |
Why?
|
| Connective Tissue Diseases | 1 | 2011 | 7 | 0.080 |
Why?
|
| Ligaments | 1 | 2011 | 11 | 0.080 |
Why?
|
| Bone Matrix | 1 | 2010 | 18 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 576 | 0.080 |
Why?
|
| Fatigue | 1 | 2010 | 47 | 0.080 |
Why?
|
| Bone Remodeling | 1 | 2010 | 48 | 0.080 |
Why?
|
| Upper Extremity | 1 | 2010 | 52 | 0.080 |
Why?
|
| Hip Joint | 1 | 2012 | 242 | 0.080 |
Why?
|
| Time Factors | 1 | 2012 | 1257 | 0.070 |
Why?
|
| Asepsis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Graft Survival | 1 | 2008 | 84 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 2008 | 76 | 0.070 |
Why?
|
| Bone Nails | 1 | 2007 | 12 | 0.070 |
Why?
|
| Acrylic Resins | 1 | 2007 | 3 | 0.070 |
Why?
|
| Knee Joint | 1 | 2011 | 572 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 31 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2006 | 31 | 0.060 |
Why?
|
| Genotype | 1 | 2006 | 248 | 0.060 |
Why?
|
| Phenotype | 1 | 2006 | 260 | 0.060 |
Why?
|
| Femur | 1 | 2007 | 298 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2005 | 20 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 2010 | 152 | 0.050 |
Why?
|
| Equipment Design | 2 | 2013 | 120 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 3724 | 0.040 |
Why?
|
| Range of Motion, Articular | 2 | 2014 | 564 | 0.040 |
Why?
|
| Young Adult | 2 | 2014 | 1652 | 0.040 |
Why?
|
| Prosthesis Failure | 2 | 2010 | 413 | 0.030 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 2016 | 3 | 0.030 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 3 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 16 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 18 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 52 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 85 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 89 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 152 | 0.030 |
Why?
|
| Humeral Head | 1 | 2014 | 28 | 0.030 |
Why?
|
| Rotation | 1 | 2014 | 109 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 137 | 0.030 |
Why?
|
| Bone Density | 1 | 2013 | 146 | 0.020 |
Why?
|
| Sterilization | 1 | 2012 | 7 | 0.020 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2013 | 143 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 98 | 0.020 |
Why?
|
| Shoulder Impingement Syndrome | 1 | 2011 | 11 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 521 | 0.020 |
Why?
|
| Horses | 1 | 2011 | 7 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2011 | 21 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2010 | 4 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 18 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 132 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 227 | 0.020 |
Why?
|
| Sutures | 1 | 2010 | 33 | 0.020 |
Why?
|
| Joint Capsule | 1 | 2010 | 36 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 337 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 163 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 1881 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 356 | 0.020 |
Why?
|
| Swine | 1 | 2009 | 68 | 0.020 |
Why?
|
| Shoulder Injuries | 1 | 2010 | 113 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 49 | 0.020 |
Why?
|
| Rupture | 1 | 2009 | 79 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2008 | 13 | 0.020 |
Why?
|
| Sheep | 1 | 2008 | 16 | 0.020 |
Why?
|
| Biopsy | 1 | 2008 | 188 | 0.020 |
Why?
|
| Arthrometry, Articular | 1 | 2007 | 8 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2007 | 76 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2010 | 292 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2010 | 2939 | 0.010 |
Why?
|